These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2445317)

  • 1. [Antigens A and B of the HLA system in dilated cardiomyopathies related to alcohol].
    Fischbein L; Sachs RN; Geay D; Baudelot J; Coste T; Lanfranchi J
    Arch Mal Coeur Vaiss; 1987 Jun; 80(7):1171-5. PubMed ID: 2445317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [HLA A-B and DR in dilated myocardiopathies].
    Komajda M; Raffoux C; Salame E; Colombani J; Grosgogeat Y; Cabrol C; Dausset J
    Arch Mal Coeur Vaiss; 1987 Jul; 80(8):1233-7. PubMed ID: 3120659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammatory dilated cardiomyopathy (DCMI).
    Maisch B; Richter A; Sandmöller A; Portig I; Pankuweit S;
    Herz; 2005 Sep; 30(6):535-44. PubMed ID: 16170686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA-DQB1* polymorphism and associations with dilated cardiomyopathy, inflammatory dilated cardiomyopathy and myocarditis.
    Portig I; Sandmoeller A; Kreilinger S; Maisch B
    Autoimmunity; 2009 Jan; 42(1):33-40. PubMed ID: 19127454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of the inflammatory process by endomyocardial biopsy in patients with dilated cardiomyopathy based on pathological and immunohistochemical methods.
    Prochorec-Sobieszek M; Bilińska ZT; Grzybowski J; Mazurkiewicz L; Skwarek M; Walczak E; Michalak E; Cedro K; Chmielak Z; Debski A; Demkow M; Witkowski A; Wagner T; Ruzyłło W
    Kardiol Pol; 2006 May; 64(5):479-87; discussion 488. PubMed ID: 16752331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenetic risk factors of dilated cardiomyopathy.
    Popovici M; Groppa L; Kalinina L
    Blood Press Suppl; 1996; 3():49-52. PubMed ID: 8973770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotypic characterization of infiltrates in dilated cardiomyopathy - diagnostic significance of T-lymphocytes and macrophages in inflammatory cardiomyopathy.
    Noutsias M; Pauschinger M; Schultheiss H; K hl U
    Med Sci Monit; 2002 Jul; 8(7):CR478-87. PubMed ID: 12118194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [HLA typing and insulin antibody production in insulin-dependent diabetics].
    Bruni B; Barolo P; Gadaleta G; Gamba Ansaldi S; Grassi G; Zerbinati A; Molinatti M; Salvetti E
    Ann Osp Maria Vittoria Torino; 1984; 27(7-12):185-213. PubMed ID: 6443704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Peripheral T-lymphocyte subpopulations in primary and alcoholic dilated cardiomyopathy].
    Sachs RN; Hatron PY; Saizy C; Lanfranchi J
    Ann Med Interne (Paris); 1985; 136(3):229-32. PubMed ID: 3161445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The pathogenesis of dilated cardiomyopathy: current progress].
    Mestroni L; Giacca M; Severini GM; Camerini F
    G Ital Cardiol; 1992 Jan; 22(1):53-62. PubMed ID: 1624069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prevalence of HLA-A and -B antigens, anti-HBc and -HBs antibodies in alcoholic hepatopathies].
    Doffoël M; Tongio MM; Ledig M; Charrault A; Vetter D; North ML; Mayer S; Mandel P; Bockel R
    Ann Med Interne (Paris); 1985; 136(3):225-8. PubMed ID: 3875304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [HLA-associated predisposition to dilated cardiomyopathy].
    Polianskaia IS; Alekseev LP; Chumburidze VB; Iurenev AP; Guniia MG; Dubov PB; Dolbin AG
    Klin Med (Mosk); 1990 Jun; 68(6):30-3. PubMed ID: 2145467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA antigens and susceptibility to myasthenia gravis.
    Matej H; Nowakowska B; Kałamarz M; Paradowski B; Podemski R; Brzecki A
    Arch Immunol Ther Exp (Warsz); 1987; 35(6):795-801. PubMed ID: 3508039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The incidence of major histocompatibility system antigens in dilated and ischemic myocardiopathies].
    Almenar L; Montoro J; Palencia M; Puig N; Molina R; Reyes I; Chirivella M; Moreno MT; Díez JL; Algarra F
    Rev Esp Cardiol; 1995 Oct; 48(10):666-70. PubMed ID: 7481035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigens of the major histocompatibility system in ischemic heart disease and idiopathic dilated cardiomyopathy.
    Osa A; Almenar L; Palencia M; Puig N; Chirivella M; Montoro J
    Clin Cardiol; 1999 Apr; 22(4):292-6. PubMed ID: 10198739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [HLA antigens in patients with primary cardiomyopathy].
    Pietrzak M; Zebrowski A; Krzemińska-Pakuła M; Kaczmarek A; Miś J
    Kardiol Pol; 1988; 31(9):598-604. PubMed ID: 3244236
    [No Abstract]   [Full Text] [Related]  

  • 17. [Immunologic studies in patients with dilated cardiomyopathy].
    Vogt S; Ewers P; Goos H; Krosse B; Löbe M; Ladusch M; Seim K; Wolff M
    Z Gesamte Inn Med; 1992 Apr; 47(4):159-62. PubMed ID: 1595301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Familial dilated cardiomyopathy: evidence for clinical and immunogenetic heterogeneity.
    Bilińska ZT; Michalak E; Piatosa B; Grzybowski J; Skwarek M; Deptuch TW; Kuśmierczyk-Droszcz B; Piotrowski W; Ruzyłło W
    Med Sci Monit; 2003 May; 9(5):CR167-74. PubMed ID: 12761452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Scleroderma and HLA antigens].
    Holzmann H; Sollberg S; Schütz K; Kühnl P
    Hautarzt; 1989 Mar; 40(3):134-40. PubMed ID: 2714991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Genetic aspects of hypertrophic cardiomyopathy (familial studies and relation of HLA to obstructive hypertrophic cardiomyopathy)].
    Moiseev VS; Polianskaia IS; Iazdovskiĭ VV; Korovina EP; Guniia MG
    Ter Arkh; 1987; 59(8):82-5. PubMed ID: 3500526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.